Equities

Skyward Specialty Insurance Group Inc

Skyward Specialty Insurance Group Inc

Actions
  • Price (EUR)49.00
  • Today's Change1.00 / 2.08%
  • Shares traded33.00
  • 1 Year change+77.54%
  • Beta--
Data delayed at least 15 minutes, as of Nov 22 2024 07:13 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Skyward Specialty Insurance Group, Inc. is a specialty insurance company. The Company is focused on delivering commercial property casualty (P&C) products and solutions on a non-admitted (E&S) and admitted basis, predominantly in the United States. It operates through eight underwriting divisions: Accident & Health, Captives, Global Property and Agriculture, Industry Solutions, Professional Lines, Programs, Surety and Transactional E&S. Its Accident & Health (A&H) underwriting division provides a medical stop loss solution targeting organizations with less than 2,500 employees. Its Captives underwriting division provides group captive solutions by drawing on its underwriting and claims expertise from other underwriting divisions to create group captives for companies seeking to self-insure. Its Industry Solutions underwriting division includes three underwriting units that each provide multiple coverages to the businesses they serve: Construction, Energy and Specialty Trucking.

  • Revenue in USD (TTM)1.07bn
  • Net income in USD133.50m
  • Incorporated2006
  • Employees515.00
  • Location
    Skyward Specialty Insurance Group Inc800 Gessner, Suite 600HOUSTON 77024United StatesUSA
  • Phone+1 (713) 935-4888
  • Fax+1 (302) 636-5454
  • Websitehttps://www.skywardinsurance.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.